Regeneron is conducting a study enrolling male participants with Hemophilia B.

You may help progress the understanding of hemophilia B.

Honey-B aims to evaluate disease characteristics in people with hemophilia B that are receiving FIX prophylaxis. This website provides information about a study, Honey-B, for boys and men with hemophilia B. Hemophilia B is a rare genetic disease characterized by abnormally low amounts of functional Factor IX (factor nine) protein. Factor IX (FIX) is a protein made naturally in the body and helps the blood form clots to stop bleeding. FIX is expressed by a gene located on the X chromosome. Men have only one X chromosome while women have two X chromosomes. Because of this, severe hemophilia more often affects men as they do not have a second copy of the gene. People with moderate and severe hemophilia B have spontaneous bleeding inside the body, pain, and heavy bleeding after a cut or injury.

This disease affects about 4 in every 100,000 men worldwide, according to the World Federation of Hemophilia (WFH).


Studies help doctors better understand how a disease affects patients and how a potential treatment for the disease works in the body. This study plays an important role in increasing doctors’ understanding of hemophilia B, which may help other people with hemophilia B in the future.

Learn more about Honey-B and see if it may be an option for you or someone you know.

en_USEnglish (United States)
Please enable JavaScript in your browser to complete this form.
How valuable was the information provided on our site for you?
Not at all Likely Extremely Likely
Please check if you would like to answer more questions about website user experience